another 24 h of incubation in 5% CO2 at 35°C for additional growth of beta-hemolytic streptococci.
Rapid diagnostic methodologies are changing traditional approaches to clinical microbiology (3, 5 another 24 h of incubation in 5% CO2 at 35°C for additional growth of beta-hemolytic streptococci.
Cultural identification. All beta-hemolytic streptococcal isolates were tested by the 0.04 Unit Taxo A bacitracin disk (BBL) sensitivity method. Any zone of inhibition after overnight incubation at 35°C in 5% CO2 was considered positive for group A beta-hemolytic streptococci. Each betahemolytic streptococcal isolates was also grouped as A, B, C, D, F, G, or non-group A-G by the Streptex Rapid Latex Test Kit (Wellcome Research Laboratories, Beckenham, England). The instructions of the manufacturer were followed.
DGAST. After each appropriately labeled swab was inoculated onto a 5% sheep blood plate, a DGAST was performed. The swab was placed into a numbered glass test tube (12 by 75 mm) containing 0.5 ml of extraction reagent, which was vortexed for 5 s and then incubated in a 35°C heat block for 1 h. After incubation, as mich extract as possible was expelled from the swab before testing. Fifty microliters of extract was mixed with anti-group A reagent (antibodycoated latex particles specific for group A beta-hemolytic streptococci) on a glass slide. After 4 min of rotation at 100 rpm, the agglutination of latex particles in the mixture was determined by using a direct light.
Of the 500 samples, 366 (73.6%) were DGAST negative and 134 (26.8%) were DGAST positive. No beta-hemolytic streptococci were recovered from 256 (51.2%) of the cultures. Beta-hemolytic streptococci were found in the remaining 244 (48.8%) cultures. Of these, 144 (59%) were group A beta-hemolytic streptococci and 100 (41%) were non-group A beta-hemolytic streptococci. Of the non-group A betahemolytic streptococci grown, 45 (45%) were group C, 22 (22%) were group F, 18 (18%) were group G, 9 (9%) were group B, and 6 (6%) were non-group A-G. As has been noted in previous studies, we found the predominant non-group A beta-hemolytic streptococci to be groups C, F, and G, in that order (4, 6) . (Table 1) .
We divided the samples in our study into pediatric and adult specimens to determine whether the DGAST might be more effective with one population than with the other. Approximately half of the patients in the study were pediatric (258), and the other half were adult (242). Approximately three times as many group A beta-hemolytic streptococci were isolated from the pediatric specimens (111) as from the adult specimens (33). The distribution of non-group A betahemolytic streptococci between the two population groups was the same.
The predictive value of a positive DGAST for the pediatric population was 98.1% (99/101). The predictive value of a positive DGAST for the adult population was 96.9% (32/33).
The predictive value for a negative DGAST for the adult population was 99.5% (208/209). The predictive value for a negative DGAST in the pediatric population was 92.3% (145/ 157) ( Table 2 ).
There were three specimens which were positive for group A beta-hemolytic streptococci by the DGAST but negative by culture. One possible explanation for this phenomenon is the use of over-the-counter cold remedies which render the bacteria nonviable but antigenically reactive (K. P. Aspden, Abstr, Annu. Meet. Am. Soc. Microbiol. 1984, C210, p.
270).
Of the 13 culture-positive, DGAST-negative specimens, 9 contained 1+ to 2+ growth patterns of beta-hemolytic streptococci. Possibly the low numbers of group A betahemolytic streptococci in the specimens account for the negative DGAST results. We found that the Taxo A bacitracin disk was 100% accurate in identifying group A beta-hemolytic streptococci as group A but less accurate in detecting non-group A betahemolytic streptococci. Our results concur with other studies in demonstrating that 13% of group C beta-hemolytic streptococci and 11% of group G beta-hemolytic streptococci are sensitive to the Bacitracin disk (6) .
Many laboratories are considering whether to perform the DGAST alone or to supplement it with a culture. Our study suggests that a supplemental culture would be of value. Although the predictive value of a positive DGAST is quite high, the predictive value of a negative DGAST for the pediatric population indicates that ca. 8% of group A betahemolytic streptococci would be missed by DGAST alone. A backup culture would also aid in detection of other possible agents of pharyngitis (2) .
The cost of performing the DGAST is greater than that of culture alone. The benefits of DGAST warrant the additional expenditure. The rapid results allow the physician to treat promptly and appropriately, thereby preventing any sequelae due to group A beta-hemolytic streptococcal infection, and also aid in preventing the overuse of antimicrobial agents. The DGAST is easy to perform and suitable for use in clinical laboratories.
